Almanac 2013: Cardiac Arrhythmias and Pacing—An Editorial Overview of Selected Research That Has Driven Recent Advances in Clinical Cardiology
Summary
Atrial fibrillation
Epidemiology of atrial fibrillation
Medical management of AF
Monitoring and assessment of AF
Catheter ablation of AF
Strategies to decrease thromboembolism
Cardiac resynchronisation therapy and pacing
Cardiac resynchronisation therapy
Heart block and pacemakers
Ventricular arrhythmias and sudden cardiac death
Epidemiology of sudden cardiac death
Implantable cardioverter defibrillators
Out-of-hospital cardiac arrest
Conclusions
Competing interests
References
- Huxley, R.R.; Alonso, A.; Lopez, F.L.; et al. Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study. Heart 2012, 98, 133–138. [Google Scholar] [CrossRef]
- Emilsson, L.; Smith, J.G.; West, J.; et al. Increased risk of atrial fibrillation in patients with coeliac disease: a nationwide cohort study. Eur Heart J. 2011, 32, 2430–2437. [Google Scholar] [CrossRef]
- Lindhardsen, J.; Ahlehoff, O.; Gislason, G.H.; et al. Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study. BMJ 2012, 344, e1257. [Google Scholar] [CrossRef] [PubMed]
- Ahlehoff, O.; Gislason, G.H.; Jorgensen, C.H.; et al. Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study. Eur Heart J. 2012, 33, 2054–2064. [Google Scholar] [CrossRef] [PubMed]
- Schmidt, M.; Christiansen, C.F.; Mehnert, F.; et al. Non-steroidal antiinflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study. BMJ 2011, 343, d3450. [Google Scholar] [CrossRef]
- Rosenberg, M.A.; Patton, K.K.; Sotoodehnia, N.; et al. The impact of height on the risk of atrial fibrillation: the Cardiovascular Health Study. Eur Heart J 2012, 33, 2709–2717. [Google Scholar] [CrossRef] [PubMed]
- Ball, J.; Carrington, M.J.; Stewart, S. Mild cognitive impairment in highrisk patients with chronic atrial fibrillation: a forgotten component of clinical management? Heart 2013, 99, 542–547. [Google Scholar] [CrossRef]
- Wu, J.H.Y.; Lemaitre, R.N.; King, I.B.; et al. Association of plasma phospholipid long-chain omega-3 fatty acids with incident atrial fibrillation in older adults: the Cardiovascular Health Study. Circulation 2012, 125, 1084–1093. [Google Scholar] [CrossRef]
- Bansal, N.; Fan, D.; Hsu, Cy; et al. Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation 2013, 127, 569–574. [Google Scholar] [CrossRef]
- Jabre, P.; Jouven, X.; Adnet, Fdr; et al. Atrial fibrillation and death after myocardial infarction: a community study. Circulation 2011, 123, 2094–2100. [Google Scholar] [CrossRef]
- Friberg, L.; Benson, L.; Rosenqvist, M.; et al. Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study. BMJ 2012, 344, e3522. [Google Scholar] [CrossRef]
- Avgil, T.M.; Jackevicius, C.A.; Rahme, E.; et al. Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation. JAMA 2012, 307, 1952–1958. [Google Scholar] [CrossRef] [PubMed]
- Conen, D.; Chae, C.U.; Glynn, R.J.; et al. Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA 2011, 305, 2080–2087. [Google Scholar] [CrossRef] [PubMed]
- Steg, P.G.; Alam, S.; Chiang, C.E.; et al. Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry. Heart 2012, 98, 195–201. [Google Scholar] [CrossRef] [PubMed]
- Camm, A.J.; Breithardt, G+; Crijns, H.; et al. Real-life observations of clinical outcomes with rhythmand rate-control therapies for atrial fibrillation: RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation). J Am Coll Cardiol 2011, 58, 493–501. [Google Scholar] [CrossRef]
- Van Gelder, I.C.; Groenveld, H.F.; Crijns, H.J.; et al. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med 2010, 362, 1363–1373. [Google Scholar] [CrossRef]
- Groenveld, H.F.; Crijns, H.J.G.M.; Van den Berg, M.P.; et al. The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) study. J Am Coll Cardiol 2011, 58, 1795–1803. [Google Scholar] [CrossRef]
- Smit, M.D.; Crijns, H.J.G.M.; Tijssen, J.G.P.; et al. Effect of lenient versus strict rate control on cardiac remodeling in patients with atrial fibrillation: data of the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) study. J Am Coll Cardiol 2011, 58, 942–949. [Google Scholar] [CrossRef]
- Saksena, S.; Slee, A.; Waldo, A.L.; et al. Cardiovascular outcomes in the AFFIRM trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management): an assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses. J Am Coll Cardiol 2011, 58, 1975–1985. [Google Scholar] [CrossRef]
- Yamase, M.; Nakazato, Y.; Daida, H. Effectiveness of amiodarone versus bepridil in achieving conversion to sinus rhythm in patients with persistent atrial fibrillation: a randomised trial. Heart 2012, 98, 1067–1071. [Google Scholar] [CrossRef]
- Liu, T.; Korantzopoulos, P.; Shehata, M.; et al. Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials. Heart 2011, 97, 1034–1040. [Google Scholar] [CrossRef]
- Macchia, A.; Grancelli, H.; Varini, S.; et al. Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial. J Am Coll Cardiol 2013, 61, 463–468. [Google Scholar] [CrossRef]
- Mozaffarian, D.; Marchioli, R.; Macchia, A.; et al. Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial. JAMA. 2012, 308, 2001–2011. [Google Scholar] [CrossRef] [PubMed]
- Nodari, S.; Triggiani, M.; Campia, U.; et al. n-3 Polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study. Circulation 2011, 124, 1100–1106. [Google Scholar] [CrossRef] [PubMed]
- Healey, J.S.; Connolly, S.J.; Gold, M.R.; et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012, 366, 120–129. [Google Scholar] [CrossRef]
- Ritter, M.A.; Kochhauser, S.; Duning, T.; et al. Occult atrial fibrillation in cryptogenic stroke: detection by 7-day electrocardiogram versus implantable cardiac monitors. Stroke 2013, 44, 1449–1452. [Google Scholar] [CrossRef]
- Mittal, S.; Movsowitz, C.; Steinberg, J.S. Ambulatory external electrocardiographic monitoring: focus on atrial fibrillation. J Am Coll Cardiol 2011, 58, 1741–1749. [Google Scholar] [CrossRef]
- Roten, L.; Schilling, M.; Haberlin, A.; et al. Is 7-day event triggered ECG recording equivalent to 7-day Holter ECG recording for atrial fibrillation screening? Heart 2012, 98, 645–649. [Google Scholar] [CrossRef] [PubMed]
- Charitos, E.I.; Stierle, U.; Ziegler, P.D.; et al. A comprehensive evaluation of rhythm monitoring strategies for the detection of atrial fibrillation recurrence: insights from 647 continuously monitored patients and implications for monitoring after therapeutic interventions. Circulation 2012, 126, 806–814. [Google Scholar] [CrossRef]
- Deftereos, S.; Giannopoulos, G.; Kossyvakis, C.; et al. Estimation of atrial fibrillation recency of onset and safety of cardioversion using NTproBNP levels in patients with unknown time of onset. Heart. 2011, 97, 914–917. [Google Scholar] [CrossRef]
- Cosedis Nielsen, J.; Johannessen, A.; Raatikainen, P.; et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med 2012, 367, 1587–1595. [Google Scholar] [CrossRef]
- MacDonald, M.R.; Connelly, D.T.; Hawkins, N.M.; et al. Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial. Heart 2011, 97, 740–747. [Google Scholar] [CrossRef]
- Hunter, R.J.; McCready, J.; Diab, I.; et al. Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death. Heart 2012, 98, 48–53. [Google Scholar] [CrossRef]
- Miyazaki, S.; Kuwahara, T.; Kobori, A.; et al. Long-term clinical outcome of extensive pulmonary vein isolation-based catheter ablation therapy in patients with paroxysmal and persistent atrial fibrillation. Heart 2011, 97, 668–673. [Google Scholar] [CrossRef]
- Mun, H.S.; Joung, B.; Shim, J.; et al. Does additional linear ablation after circumferential pulmonary vein isolation improve clinical outcome in patients with paroxysmal atrial fibrillation? Prospective randomised study. Heart 2012, 98, 480–484. [Google Scholar] [CrossRef] [PubMed]
- Chao, T.F.; Sung, S.H.; Wang, K.L.; et al. Associations between the atrial electromechanical interval, atrial remodelling and outcome of catheter ablation in paroxysmal atrial fibrillation. Heart 2011, 97, 225–230. [Google Scholar] [CrossRef] [PubMed]
- den Uijl, D.W.; Delgado, V.; Bertini, M.; et al. Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation. Heart 2011, 97, 1847–1851. [Google Scholar] [CrossRef]
- Wong, C.X.; Abed, H.S.; Molaee, P.; et al. Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J Am Coll Cardiol 2011, 57, 1745–1751. [Google Scholar] [CrossRef] [PubMed]
- Hussein, A.A.; Saliba, W.I.; Martin, D.O.; et al. Plasma B-type natriuretic peptide levels and recurrent arrhythmia after successful ablation of lone atrial fibrillation. Circulation 2011, 123, 2077–2082. [Google Scholar] [CrossRef]
- Tokuda, M.; Yamane, T.; Matsuo, S.; et al. Relationship between renal function and the risk of recurrent atrial fibrillation following catheter ablation. Heart 2011, 97, 137–142. [Google Scholar] [CrossRef]
- Mohanty, S.; Mohanty, P.; Di Biase, L.; et al. Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation. J Am Coll Cardiol 2012, 59, 1295–1301. [Google Scholar] [CrossRef]
- Lee, G.; Kalman, J.M.; Vohra, J.K.; et al. Dissociated pulmonary vein potentials following antral pulmonary vein isolation for atrial fibrillation: impact on long-term outcome. Heart 2011, 97, 579–584. [Google Scholar] [CrossRef]
- Deftereos, S.; Giannopoulos, G.; Kossyvakis, C.; et al. Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study. J Am Coll Cardiol 2012, 60, 1790–1796. [Google Scholar] [CrossRef] [PubMed]
- Imazio, M.; Brucato, A.; Ferrazzi, P.; et al. Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation 2011, 124, 2290–2295. [Google Scholar] [CrossRef] [PubMed]
- Pokushalov, E.; Romanov, A.; Corbucci, G.; et al. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol 2012, 60, 1163–1170. [Google Scholar] [CrossRef]
- Shah, R.U.; Freeman, J.V.; Shilane, D.; et al. Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. J Am Coll Cardiol 2012, 59, 143–149. [Google Scholar] [CrossRef] [PubMed]
- Chao, T.F.; LINYJ. ; TSAOHM; et al. CHADS2 and CHA2DS2-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation. J Am Coll Cardiol 2011, 58, 2380–2385. [Google Scholar] [CrossRef][Green Version]
- Boersma, L.V.A.; Castella, M.; van Boven, W.; et al. Atrial Fibrillation Catheter Ablation Versus Surgical Ablation Treatment (FAST): a 2-center randomized clinical trial. Circulation 2012, 125, 23–30. [Google Scholar] [CrossRef]
- Pison, L.; La Meir, M.; van Opstal, J.; et al. Hybrid thoracoscopic surgical and transvenous catheter ablation of atrial fibrillation. J Am Coll Cardiol 2012, 60, 54–61. [Google Scholar] [CrossRef]
- Lopes, R.D.; Al-Khatib, S.M.; Wallentin, L.; et al. Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial. Lancet 2012, 380, 1749–1758. [Google Scholar] [CrossRef]
- Patel, M.R.; Mahaffey, K.W.; Garg, J.; et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011, 365, 883–891. [Google Scholar] [CrossRef] [PubMed]
- Granger, C.B.; Alexander, J.H.; McMurray, J.J.V.; et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011, 365, 981–992. [Google Scholar] [CrossRef]
- Connolly, S.J.; Ezekowitz, M.D.; Yusuf, S.; et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009, 361, 1139–1151. [Google Scholar] [CrossRef]
- Dentali, F.; Riva, N.; Crowther, M.; et al. Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature. Circulation 2012, 126, 2381–2391. [Google Scholar] [CrossRef]
- Nagarakanti, R.; Ezekowitz, M.D.; Oldgren, J.; et al. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion. Circulation 2011, 123, 131–136. [Google Scholar] [CrossRef]
- Maddox, W.; Kay, G.N.; Yamada, T.; et al. Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation. J Cardiovasc Electrophysiol 2013, 24, 861–865. [Google Scholar] [CrossRef]
- Bassiouny, M.; Saliba, W.; Rickard, J.; et al. Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation. Circ Arrhythm Electrophysiol 2013, 6, 460–466. [Google Scholar] [CrossRef] [PubMed]
- Kim, J.S.; She, F.; Jongnarangsin, K.; et al. Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation. Heart Rhythm 2013, 10, 483–489. [Google Scholar] [CrossRef]
- Lakkireddy, D.; Reddy, Y.M.; Di Biase, L.; et al. Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. J Am Coll Cardiol 2012, 59, 1168–1174. [Google Scholar] [CrossRef] [PubMed]
- Kansal, A.R.; Sorensen, S.V.; Gani, R.; et al. Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation. Heart 2012, 98, 573–578. [Google Scholar] [CrossRef]
- Shah, S.V.; Gage, B.F. Cost-effectiveness of dabigatran for stroke prophylaxis in atrial brillation. Circulation 2011, 123, 2562–2570. [Google Scholar] [CrossRef]
- Munkholm-Larsen, S.; Cao, C.; Yan, T.D.; et al. Percutaneous atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: a systematic review. Heart 2012, 98, 900–907. [Google Scholar] [CrossRef]
- Viles-Gonzalez, J.F.; Kar, S.; Douglas, P.; et al. The clinical impact of incomplete left atrial appendage closure with the watchman device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy. J Am Coll Cardiol 2012, 59, 923–929. [Google Scholar] [PubMed]
- Mahajan, R.; Brooks, A.G.; Sullivan, T.; et al. Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure. Heart 2012, 98, 1120–1126. [Google Scholar] [CrossRef] [PubMed]
- Leong, D.P.; Hoke, U.; Delgado, V.; et al. Right ventricular function and survival following cardiac resynchronisation therapy. Heart 2013, 99, 722–728. [Google Scholar] [CrossRef] [PubMed]
- Moss, A.J.; Hall, W.J.; Cannom, D.S.; et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009, 361, 1329–1338. [Google Scholar] [CrossRef]
- Goldenberg, I.; Hall, W.J.; Beck, C.A.; et al. Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy). J Am Coll Cardiol 2011, 58, 729–737. [Google Scholar] [CrossRef]
- Brenyo, A.; Link, M.S.; Barsheshet, A.; et al. Cardiac resynchronization therapy reduces left atrial volume and the risk of atrial tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy). J Am Coll Cardiol 2011, 58, 1682–1689. [Google Scholar] [CrossRef]
- Goldenberg, I.; Moss, A.J.; Hall, W.J.; et al. Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADITCRT). Circulation 2011, 124, 1527–1536. [Google Scholar] [CrossRef]
- Pouleur, A.C.; Knappe, D.; Shah, A.M.; et al. Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial. Eur Heart J 2011, 32, 1720–1729. [Google Scholar] [CrossRef]
- Hsu, J.C.; Solomon, S.D.; Bourgoun, M.; et al. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study. J Am Coll Cardiol 2012, 59, 2366–2373. [Google Scholar] [CrossRef]
- Veazie, P.J.; Noyes, K.; Li, Q.; et al. Cardiac resynchronization and quality of life in patients with minimally symptomatic heart failure. J Am Coll Cardiol 2012, 60, 1940–1944. [Google Scholar] [CrossRef] [PubMed]
- Singh, J.P.; Klein, H.U.; Huang, D.T.; et al. Left ventricular lead position and clinical outcome in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT) trial. Circulation 2011, 123, 1159–1166. [Google Scholar] [CrossRef] [PubMed]
- Kutyifa, V.; Zareba, W.; McNitt, S.; et al. Left ventricular lead location and the risk of ventricular arrhythmias in the MADIT-CRT trial. Eur Heart J 2013, 34, 184–190. [Google Scholar] [CrossRef] [PubMed]
- Diab, I.G.; Hunter, R.J.; Kamdar, R.; et al. Does ventricular dyssynchrony on echocardiography predict response to cardiac resynchronisation therapy? A randomised controlled study. Heart 2011, 97, 1410–1416. [Google Scholar] [CrossRef]
- Foley, P.W.X.; Patel, K.; Irwin, N.; et al. Cardiac resynchronisation therapy in patients with heart failure and a normal QRS duration: the RESPOND study. Heart 2011, 97, 1041–1047. [Google Scholar] [CrossRef]
- Zareba, W.; Klein, H.; Cygankiewicz, I.; et al. Effectiveness of cardiac resynchronization therapy by QRS morphology in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT). Circulation 2011, 123, 1061–1072. [Google Scholar] [CrossRef]
- Brignole, M.; Botto, G.; Mont, L.; et al. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial. Eur Heart J 2011, 32, 2420–2429. [Google Scholar] [CrossRef]
- Brignole, M.; Botto, G.L.; Mont, L.; et al. Predictors of clinical efficacy of ablate and pace therapy in patients with permanent atrial fibrillation. Heart 2012, 98, 297–302. [Google Scholar] [CrossRef]
- Chan, J.Y.-S.; Fang, F.; Zhang, Q.; et al. Biventricular pacing is superior to right ventricular pacing in bradycardia patients with preserved systolic function: 2-year results of the PACE trial. Eur Heart J 2011, 32, 2533–2540. [Google Scholar] [CrossRef]
- Coumbe, A.G.; Naksuk, N.; Newell, M.C.; et al. Long-term follow-up of older patients with Mobitz type I second degree atrioventricular block. Heart 2013, 99, 334–338. [Google Scholar] [CrossRef]
- van Geldorp, I.E.; Delhaas, T.; Gebauer, R.A.; et al. Impact of the permanent ventricular pacing site on left ventricular function in children: a retrospective multicentre survey. Heart 2011, 97, 2051–2055. [Google Scholar] [CrossRef]
- Brignole, M.; Menozzi, C.; Moya, A.; et al. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation 2012, 125, 2566–2571. [Google Scholar] [CrossRef]
- Deharo, J.C.; Mechulan, A.; Giorgi, R.; et al. Adenosine plasma level and A2A adenosine receptor expression: correlation with laboratory tests in patients with neurally mediated syncope. Heart 2012, 98, 855–859. [Google Scholar] [CrossRef]
- Flammang, D.; Church, T.R.; De Roy, L.; et al. Treatment of unexplained syncope: a multicenter, randomized trial of cardiac pacing guided by adenosine 50 -triphosphate testing. Circulation 2012, 125, 31–36. [Google Scholar] [CrossRef]
- Brignole, M.; Deharo, J.C.; De Roy, L.; et al. Syncope due to idiopathic paroxysmal atrioventricular block: long-term follow-up of a distinct form of atrioventricular block. J Am Coll Cardiol 2011, 58, 167–173. [Google Scholar] [CrossRef]
- Ruwald, M.H.; Hansen, M.L.; Lamberts, M.; et al. Prognosis among healthy individuals discharged with a primary diagnosis of syncope. J Am Coll Cardiol 2013, 61, 325–332. [Google Scholar] [CrossRef]
- Athan, E.; Chu, V.H.; Tattevin, P.; et al. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA 2012, 307, 1727–1735. [Google Scholar] [CrossRef] [PubMed]
- Deharo, J.C.; Quatre, A.; Mancini, J.; et al. Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study. Heart 2012, 98, 724–731. [Google Scholar] [CrossRef] [PubMed]
- Greenspon, A.J.; Prutkin, J.M.; Sohail, M.R.; et al. Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis: results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort). J Am Coll Cardiol 2012, 59, 681–687. [Google Scholar] [CrossRef] [PubMed]
- Ye, S.; Grunnert, M.; Thune, J.J.; et al. Circumstances and outcomes of sudden unexpected death in patients with high-risk myocardial infarction: implications for prevention. Circulation 2011, 123, 2674–2680. [Google Scholar] [CrossRef] [PubMed]
- Soliman, E.Z.; Prineas, R.J.; Case, L.D.; et al. Electrocardiographic and clinical predictors separating atherosclerotic sudden cardiac death from incident coronary heart disease. Heart 2011, 97, 1597–1601. [Google Scholar] [CrossRef] [PubMed]
- Marijon, E.; Tafflet, M.; Celermajer, D.S.; et al. Sports-related sudden death in the general population. Circulation 2011, 124, 672–681. [Google Scholar] [CrossRef]
- Eckart, R.E.; Shry, E.A.; Burke, A.P.; et al. Sudden death in young adults: an autopsy-based series of a population undergoing active surveillance. J Am Coll Cardiol 2011, 58, 1254–1261. [Google Scholar] [CrossRef]
- Winkel, B.G.; Holst, A.G.; Theilade, J.; et al. Nationwide study of sudden cardiac death in persons aged 1–35 years. Eur Heart J 2011, 32, 983–990. [Google Scholar] [CrossRef] [PubMed]
- Bertoia, M.L.; Allison, M.A.; Manson, J.E.; et al. Risk factors for sudden cardiac death in post-menopausal women. J Am Coll Cardiol 2012, 60, 2674–2682. [Google Scholar] [CrossRef]
- Haissaguerre, M.; Derval, N.; Sacher, F.; et al. Sudden cardiac arrest associated with early repolarization. N Engl J Med 2008, 358, 2016–2023. [Google Scholar] [CrossRef]
- Tikkanen, J.T.; Anttonen, O.; Junttila, M.J.; et al. Long-term outcome associated with early repolarization on electrocardiography. N Engl J Med 2009, 361, 2529–2537. [Google Scholar] [CrossRef]
- Derval, N.; Simpson, C.S.; Birnie, D.H.; et al. Prevalence and characteristics of early repolarization in the CASPER registry: cardiac arrest survivors with preserved ejection fraction registry. J Am Coll Cardiol 2011, 58, 722–728. [Google Scholar] [CrossRef]
- Nunn, L.M.; Bhar-Amato, J.; Lowe, M.D.; et al. Prevalence of J-point elevation in sudden arrhythmic death syndrome families. J Am Coll Cardiol 2011, 58, 286–290. [Google Scholar] [CrossRef]
- Gourraud, J.B.; Le Scouarnec, S.; Sacher, F.; et al. Identification of large families in early repolarization syndrome. J Am Coll Cardiol. 2013, 61, 164–172. [Google Scholar] [CrossRef]
- Haruta, D.; Matsuo, K.; Tsuneto, A.; et al. Incidence and prognostic value of early repolarization pattern in the 12-lead electrocardiogram. Circulation 2011, 123, 2931–2937. [Google Scholar] [CrossRef]
- Bastiaenen, R.; Behr, E.R. Early repolarisation: controversies and clinical implications. Heart 2012, 98, 841–847. [Google Scholar] [CrossRef]
- Junttila, M.J.; Sager, S.J.; Tikkanen, J.T.; et al. Clinical significance of variants of J-points and J-waves: early repolarization patterns and risk. Eur Heart J 2012, 33, 2639–2643. [Google Scholar] [CrossRef][Green Version]
- Bastiaenen, R.; Behr, E.R. Sudden death and ion channel disease: pathophysiology and implications for management. Heart 2011, 97, 1365–1372. [Google Scholar] [CrossRef]
- Nunn, L.M.; Lambiase, P.D. Genetics and cardiovascular disease – causes and prevention of unexpected sudden adult death: the role of the SADS clinic. Heart 2011, 97, 1122–1127. [Google Scholar] [CrossRef] [PubMed]
- Corrado, D.; Basso, C.; Pilichou, K.; et al. Molecular biology and clinical management of arrhythmogenic right ventricular cardiomyopathy/ dysplasia. Heart 2011, 97, 530–539. [Google Scholar] [CrossRef]
- Napolitano, C.; Bloise, R.; Monteforte, N.; et al. Sudden cardiac death and genetic ion channelopathies: long QT, Brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation. Circulation 2012, 125, 2027–2034. [Google Scholar] [CrossRef] [PubMed]
- Jamshidi, Y.; Nolte, I.M.; Dalageorgou, C.; et al. Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia. J Am Coll Cardiol 2012, 60, 841–850. [Google Scholar] [CrossRef] [PubMed]
- van Noord, C.; Sturkenboom, M.C.J.M.; Straus, S.M.J.M.; et al. Non-cardiovascular drugs that inhibit hERG-encoded potassium channels and risk of sudden cardiac death. Heart 2011, 97, 215–220. [Google Scholar] [CrossRef]
- van Rees, J.B.; Borleffs, C.J.W.; van Welsenes, G.H.; et al. Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score. Heart 2012, 98, 872–877. [Google Scholar] [CrossRef]
- Haines, D.E.; Wang, Y.; Curtis, J. Implantable cardioverter-defibrillator registry risk score models for acute procedural complications or death after implantable cardioverter-defibrillator implantation. Circulation 2011, 123, 2069–2076. [Google Scholar] [CrossRef]
- Barsheshet, A.; Moss, A.J.; Huang, D.T.; et al. Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator. J Am Coll Cardiol 2012, 59, 2075–2079. [Google Scholar] [CrossRef]
- Bilchick, K.C.; Stukenborg, G.J.; Kamath, S.; et al. Prediction of mortality in clinical practice for Medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death. J Am Coll Cardiol 2012, 60, 1647–1655. [Google Scholar] [CrossRef]
- de Haan, S.; Meijers, T.A.; Knaapen, P.; et al. Scar size and characteristics assessed by CMR predict ventricular arrhythmias in ischaemic cardiomyopathy: comparison of previously validated models. Heart 2011, 97, 1951–1956. [Google Scholar] [CrossRef]
- Klem, I.; Weinsaft, J.W.; Bahnson, T.D.; et al. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol 2012, 60, 408–420. [Google Scholar] [CrossRef] [PubMed]
- Swerdlow, C.; Chow, T.; Das, M.; et al. Intracardiac electrogram T-wave alternans/variability increases before spontaneous ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients: a prospective, multi-center study. Circulation 2011, 123, 1052–1060. [Google Scholar] [CrossRef]
- Forleo, G.B.; Tesauro, M.; Panattoni, G.; et al. Impact of continuous intracardiac ST-segment monitoring on mid-term outcomes of ICD-implanted patients with coronary artery disease. Early results of a prospective comparison with conventional ICD outcomes. Heart 2012, 98, 402–407. [Google Scholar] [CrossRef]
- Hauser, R.G.; Maisel, W.H.; Friedman, P.A.; et al. Longevity of Sprint Fidelis implantable cardioverter-defibrillator leads and risk factors for failure: implications for patient management. Circulation 2011, 123, 358–363. [Google Scholar] [CrossRef] [PubMed]
- Birnie, D.H.; Parkash, R.; Exner, D.V.; et al. Clinical predictors of Fidelis lead failure: report from the Canadian Heart Rhythm Society Device Committee. Circulation 2012, 125, 1217–1225. [Google Scholar] [CrossRef] [PubMed]
- Parkash, R.; Thibault, B.; Sterns, L.; et al. Sprint Fidelis lead fractures in patients with cardiac resynchronization therapy devices: insight from the Resynchronization/ Defibrillation for Ambulatory Heart Failure (RAFT) study. Circulation 2012, 126, 2928–2934. [Google Scholar] [CrossRef]
- Cho, E.Y.N.; von Känel, R.; Marten-Mittag, B.; et al. Determinants and trajectory of phobic anxiety in patients living with an implantable cardioverter defibrillator. Heart 2012, 98, 806–812. [Google Scholar] [CrossRef]
- Landolina, M.; Gasparini, M.; Lunati, M.; et al. Long-term complications related to biventricular defibrillator implantation: rate of surgical revisions and impact on survival: insights from the Italian Clinical Service Database. Circulation 2011, 123, 2526–2535. [Google Scholar] [CrossRef] [PubMed]
- Dewland, T.A.; Pellegrini, C.N.; Wang, Y.; et al. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry. J Am Coll Cardiol 2011, 58, 1007–1013. [Google Scholar] [CrossRef]
- O’Mahony, C.; Lambiase, P.D.; Quarta, G.; et al. The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy. Heart 2012, 98, 116–125. [Google Scholar] [CrossRef] [PubMed]
- Swerdlow, C.D.; Sachanandani, H.; Gunderson, B.D.; et al. Preventing overdiagnosis of implantable cardioverter-defibrillator lead fractures using device diagnostics. J Am Coll Cardiol 2011, 57, 2330–2339. [Google Scholar] [CrossRef]
- Moss, A.J.; Schuger, C.; Beck, C.A.; et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012, 367, 2275–2283. [Google Scholar] [CrossRef] [PubMed]
- Olde Nordkamp, L.R.A.; Dabiri Abkenari, L.; Boersma, L.V.A.; et al. The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. J Am Coll Cardiol 2012, 60, 1933–1939. [Google Scholar] [CrossRef]
- Jarman, J.W.E.; Lascelles, K.; Wong, T.; et al. Clinical experience of entirely subcutaneous implantable cardioverter defibrillators in children and adults: cause for caution. Eur Heart J 2012, 33, 1351–1359. [Google Scholar] [CrossRef]
- Lyman, S.; Sedrakyan, A.; Do, H.; et al. Infrequent physician use of implantable cardioverter-defibrillators risks patient safety. Heart 2011, 97, 1655–1660. [Google Scholar] [CrossRef]
- Caldwell, J.; Moreton, N.; Khan, N.; et al. The clinical management of relatives of young sudden unexplained death victims; implantable defibrillators are rarely indicated. Heart 2012, 98, 631–636. [Google Scholar] [CrossRef] [PubMed]
- Perkins, G.D.; Brace, S.J.; Smythe, M.; et al. Out-of-hospital cardiac arrest: recent advances in resuscitation and effects on outcome. Heart 2012, 98, 529–535. [Google Scholar] [CrossRef] [PubMed]
- Nolan, J.P.; Lyon, R.M.; Sasson, C.; et al. Advances in the hospital management of patients following an out of hospital cardiac arrest. Heart 2012, 98, 1201–1206. [Google Scholar] [CrossRef] [PubMed]
- Fothergill, R.T.; Watson, L.R.; Chamberlain, D.; et al. Increases in survival from out-of-hospital cardiac arrest: a five year study. Resuscitation 2013, 84, 1089–1092. [Google Scholar] [CrossRef]
- Adielsson, A.; Hollenberg, J.; Karlsson, T.; et al. Increase in survival and bystander CPR in out-of-hospital shockable arrhythmia: bystander CPR and female gender are predictors of improved outcome. Experiences from Sweden in an 18-year perspective. Heart 2011, 97, 1391–1396. [Google Scholar] [CrossRef]
- Weisfeldt, M.L.; Everson-Stewart, S.; Sitlani, C.; et al. Ventricular tachyarrhythmias after cardiac arrest in public versus at home. N Engl J Med 2011, 364, 313–321. [Google Scholar] [CrossRef]
- Stub, D.; Smith, K.; Bray, J.E.; et al. Hospital characteristics are associated with patient outcomes following out-of-hospital cardiac arrest. Heart 2011, 97, 1489–1494. [Google Scholar] [CrossRef]
- Bardai, A.; Berdowski, J.; van der Werf, C.; et al. Incidence, causes, and outcomes of out-of-hospital cardiac arrest in children: a comprehensive, prospective, population-based study in the Netherlands. J Am Coll Cardiol. 2011, 57, 1822–1828. [Google Scholar] [CrossRef]
- Meier, P.; Baker, P.; Jost, D.; et al. Chest compressions before defibrillation for out-of-hospital cardiac arrest: a meta-analysis of randomized controlled clinical trials. BMC Med 2010, 8, 52. [Google Scholar] [CrossRef]
- Iwami, T.; Kitamura, T.; Kawamura, T.; et al. Chest compression-only cardiopulmonary resuscitation for out-of-hospital cardiac arrest with public-access defibrillation: a nationwide cohort study. Circulation 2012, 126, 2844–2851. [Google Scholar] [CrossRef]
- Kitamura, T.; Iwami, T.; Kawamura, T.; et al. Conventional and chestcompression-only cardiopulmonary resuscitation by bystanders for children who have out-of-hospital cardiac arrests: a prospective, nationwide, population-based cohort study. Lancet 2010, 375, 1347–1354. [Google Scholar] [CrossRef] [PubMed]
- Ogawa, T.; Akahane, M.; Koike, S.; et al. Outcomes of chest compression only CPR versus conventional CPR conducted by lay people in patients with out of hospital cardiopulmonary arrest witnessed by bystanders: nationwide population based observational study. BMJ 2011, 342, c7106. [Google Scholar] [CrossRef] [PubMed]
© 2014 by the author. Attribution - Non-Commercial - NoDerivatives 4.0.
Share and Cite
Liew, R. Almanac 2013: Cardiac Arrhythmias and Pacing—An Editorial Overview of Selected Research That Has Driven Recent Advances in Clinical Cardiology. Cardiovasc. Med. 2014, 17, 56. https://doi.org/10.4414/cvm.2014.00192
Liew R. Almanac 2013: Cardiac Arrhythmias and Pacing—An Editorial Overview of Selected Research That Has Driven Recent Advances in Clinical Cardiology. Cardiovascular Medicine. 2014; 17(2):56. https://doi.org/10.4414/cvm.2014.00192
Chicago/Turabian StyleLiew, Reginald. 2014. "Almanac 2013: Cardiac Arrhythmias and Pacing—An Editorial Overview of Selected Research That Has Driven Recent Advances in Clinical Cardiology" Cardiovascular Medicine 17, no. 2: 56. https://doi.org/10.4414/cvm.2014.00192
APA StyleLiew, R. (2014). Almanac 2013: Cardiac Arrhythmias and Pacing—An Editorial Overview of Selected Research That Has Driven Recent Advances in Clinical Cardiology. Cardiovascular Medicine, 17(2), 56. https://doi.org/10.4414/cvm.2014.00192